Jilan Liu

543 total citations
22 papers, 405 citations indexed

About

Jilan Liu is a scholar working on Molecular Biology, Cancer Research and Rheumatology. According to data from OpenAlex, Jilan Liu has authored 22 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Rheumatology. Recurrent topics in Jilan Liu's work include Moyamoya disease diagnosis and treatment (3 papers), Phytochemistry and Bioactivity Studies (3 papers) and MicroRNA in disease regulation (3 papers). Jilan Liu is often cited by papers focused on Moyamoya disease diagnosis and treatment (3 papers), Phytochemistry and Bioactivity Studies (3 papers) and MicroRNA in disease regulation (3 papers). Jilan Liu collaborates with scholars based in China, United States and Australia. Jilan Liu's co-authors include Alexander Khorlin, Alokes Majumdar, Michael M. Seidman, Natalia Dyatkina, Kyoichi A. Watanabe, Peter M. Glazer, James Powell, Feng Lin, Wei‐Sing Chu and Qi Liang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Nature Biotechnology.

In The Last Decade

Jilan Liu

21 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jilan Liu China	10	335	61	41	34	27	22	405
Poornima H. Neela United States	7	313 0.9×	40 0.7×	13 0.3×	17 0.5×	37 1.4×	7	419
Lisa Gawriyski Finland	9	212 0.6×	27 0.4×	16 0.4×	22 0.6×	23 0.9×	11	326
Yan Xue China	12	217 0.6×	26 0.4×	30 0.7×	104 3.1×	24 0.9×	25	393
Runxin Wu China	9	171 0.5×	89 1.5×	22 0.5×	15 0.4×	29 1.1×	19	357
Alev Baysoy United States	4	391 1.2×	101 1.7×	42 1.0×	16 0.5×	141 5.2×	4	573
Faying Liu China	12	173 0.5×	72 1.2×	28 0.7×	55 1.6×	33 1.2×	37	388
Luang Xu China	8	415 1.2×	125 2.0×	16 0.4×	72 2.1×	32 1.2×	8	487
Chen-Ching Lin Taiwan	14	461 1.4×	206 3.4×	40 1.0×	12 0.4×	23 0.9×	18	555
Paolo Maietta Spain	8	370 1.1×	50 0.8×	43 1.0×	13 0.4×	20 0.7×	12	448
K. Jill McAfee United States	4	495 1.5×	98 1.6×	16 0.4×	57 1.7×	35 1.3×	5	557

Countries citing papers authored by Jilan Liu

Since Specialization

Citations

This map shows the geographic impact of Jilan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jilan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jilan Liu more than expected).

Fields of papers citing papers by Jilan Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jilan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jilan Liu. The network helps show where Jilan Liu may publish in the future.

Co-authorship network of co-authors of Jilan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jilan Liu. A scholar is included among the top collaborators of Jilan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jilan Liu. Jilan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Baoyu, Yanli Wu, Ting Liu, et al.. (2025). Targeting AQP5-mediated arginine deprivation in gastric cancer stem cells restores NK cell anti-tumor immunity. Cell Reports Medicine. 6(9). 102333–102333.

Zhang, Lu, et al.. (2024). Shikonin Induces Glioma Necroptosis, Stemness Decline, and Impedes (Immuno)Proteasome Activity. Stem Cells International. 2024(1). 1348269–1348269. 2 indexed citations

Liu, Jilan, et al.. (2024). Plasma-derived exosomes contributes to endothelial-to-mesenchymal transition in Moyamoya disease. Heliyon. 10(5). e26748–e26748. 6 indexed citations

Zhang, Xiaobei, Jin Meng, Xiaoying Yao, et al.. (2024). Upregulation of LncRNA WT1-AS Inhibits Tumor Growth and Promotes Autophagy in Gastric Cancer via Suppression of PI3K/Akt/mTOR Pathway. Current Molecular Pharmacology. 17. e18761429318398–e18761429318398. 6 indexed citations

Liu, Jilan, et al.. (2023). Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/AKT Signaling Pathways. Cellular and Molecular Neurobiology. 43(8). 3929–3942. 5 indexed citations

Su, Yu, et al.. (2022). The relationship between hemoglobin and triglycerides in moyamoya disease: A cross-sectional study. Frontiers in Neurology. 13. 994341–994341. 2 indexed citations

Liu, Jilan, et al.. (2022). High-efficiency and durable glycerol-based reactive flame retardants for cotton fabric. Textile Research Journal. 93(7-8). 1628–1640. 1 indexed citations

Cui, Changmeng, Song Feng, Jilan Liu, et al.. (2021). Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio in Patients With Newly Diagnosed Moyamoya Disease: A Cross-Sectional Study. Frontiers in Neurology. 12. 631454–631454. 7 indexed citations

Liu, Jilan, et al.. (2021). Corilagin induces human glioblastoma U251 cell apoptosis by impeding activity of (immuno)proteasome. Oncology Reports. 45(4). 4 indexed citations

10.

Yap, Kevin Yi‐Lwern, Jilan Liu, Thomas Franchi, & Riaz Agha. (2021). The Launch of the International Journal of Digital Health: Ensuring Digital Transformation in Healthcare Beyond Covid-19. 1(1). 2–2. 2 indexed citations

11.

Liu, Jilan, et al.. (2021). An Overview of Healthcare Information Technologies Used to Combat the COVID-19 Pandemic in China. 1(1). 14–14. 2 indexed citations

12.

Liu, Jilan, Shu Jia, Xiaobei Zhang, et al.. (2021). Corilagin induces apoptosis and autophagy in NRF2‑addicted U251 glioma cell line. Molecular Medicine Reports. 23(5). 16 indexed citations

13.

Liu, Jilan, et al.. (2019). Amino Acid-Mediated Metabolism: A New Power to Influence Properties of Stem Cells. Stem Cells International. 2019. 1–9. 10 indexed citations

14.

Wang, Yangyang, Jiping Zeng, Xue Geng, et al.. (2016). MiR-320a inhibits gastric carcinoma by targeting activity in the FoxM1-P27KIP1 axis. Oncotarget. 7(20). 29275–29286. 32 indexed citations

15.

Liu, Jia, Alokes Majumdar, Jilan Liu, Lawrence H. Thompson, & Michael M. Seidman. (2010). Sequence Conversion by Single Strand Oligonucleotide Donors via Non-homologous End Joining in Mammalian Cells. Journal of Biological Chemistry. 285(30). 23198–23207. 19 indexed citations

16.

Chu, Wei‐Sing, Qi Liang, Jilan Liu, et al.. (2005). A nondestructive molecule extraction method allowing morphological and molecular analyses using a single tissue section. Laboratory Investigation. 85(11). 1416–1428. 55 indexed citations

17.

Chu, Wei‐Sing, Qi Liang, Yaoliang Tang, et al.. (2005). Ultrasound-accelerated Tissue Fixation/Processing Achieves Superior Morphology and Macromolecule Integrity with Storage Stability. Journal of Histochemistry & Cytochemistry. 54(5). 503–513. 20 indexed citations

18.

Liu, Jilan, et al.. (2003). Research on smart antenna technology for terminals for the TD-SCDMA system. IEEE Communications Magazine. 41(6). 116–119. 13 indexed citations

19.

Culver, Kenneth W., Wang‐Ting Hsieh, Yentram Huyen, et al.. (1999). Correction of chromosomal point mutations in human cells with bifunctional oligonucleotides. Nature Biotechnology. 17(10). 989–993. 50 indexed citations

20.

Majumdar, Alokes, Alexander Khorlin, Natalia Dyatkina, et al.. (1998). Targeted gene knockout mediated by triple helix forming oligonucleotides. Nature Genetics. 20(2). 212–214. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact